TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 1 filers reported holding TAYSHA GENE THERAPIES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 19 | -87.3% | 0.00% | – |
| Q2 2023 | $0 | – | 150 | +581.8% | 0.00% | – |
| Q1 2023 | $0 | – | 22 | -8.3% | 0.00% | – |
| Q4 2022 | $0 | – | 24 | +26.3% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 19 | -98.1% | 0.00% | – |
| Q2 2022 | $4,000 | -75.0% | 1,019 | -57.7% | 0.00% | – |
| Q1 2022 | $16,000 | -69.8% | 2,411 | -47.8% | 0.00% | – |
| Q4 2021 | $53,000 | +39.5% | 4,615 | +128.8% | 0.00% | – |
| Q3 2021 | $38,000 | +18.8% | 2,017 | +31.7% | 0.00% | – |
| Q2 2021 | $32,000 | +77.8% | 1,532 | +75.1% | 0.00% | – |
| Q1 2021 | $18,000 | +50.0% | 875 | +86.6% | 0.00% | – |
| Q4 2020 | $12,000 | – | 469 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 1,391,190 | $29,493,000 | 22.62% |
| Octagon Capital Advisors LP | 320,440 | $6,793,000 | 1.41% |
| Artal Group S.A. | 1,040,882 | $22,067,000 | 0.45% |
| Alphabet Inc. | 640,882 | $13,587,000 | 0.28% |
| Nantahala Capital Management | 432,072 | $9,160,000 | 0.26% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $10,600,000 | 0.22% |
| TimesSquare Capital Management, LLC | 683,400 | $14,488,000 | 0.12% |
| Perceptive Advisors | 640,880 | $13,586,000 | 0.09% |
| Virtus ETF Advisers LLC | 8,697 | $184,000 | 0.08% |
| Granite Point Capital Management, L.P. | 50,000 | $1,060,000 | 0.04% |